• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉旁路移植手术禁忌患者行左主干冠状动脉支架置入术的短期和长期预后

Short- and Long-Term Outcomes of Left Main Coronary Artery Stenting in Patients Disqualified from Coronary Artery Bypass Graft Surgery.

作者信息

Skorupski Wojciech Jan, Kałużna-Oleksy Marta, Lesiak Maciej, Araszkiewicz Aleksander, Skorupski Włodzimierz, Grajek Stefan, Mitkowski Przemysław, Pyda Małgorzata, Grygier Marek

机构信息

1st Department of Cardiology, Poznań University of Medical Sciences, 61-848 Poznań, Poland.

出版信息

J Pers Med. 2022 Feb 25;12(3):348. doi: 10.3390/jpm12030348.

DOI:10.3390/jpm12030348
PMID:35330348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8953089/
Abstract

The study aims to evaluate the short- and long-term outcomes of left main percutaneous coronary interventions (LM PCI) in patients disqualified from coronary artery bypass graft surgery (CABG). We included 459 patients (mean age: 68.4 ± 9.4 years, 24.4% females), with at least 1-year follow-up; 396 patients in whom PCI was offered as an alternative to CABG (Group 1); and 63 patients who were disqualified from CABG by the Heart Team (Group 2). The SYNTAX score (29.1 ± 9.5 vs. 23.2 ± 9.7; p < 0.001) and Euroscore II value (2.72 ± 2.01 vs. 2.15 ± 2.16; p = 0.007) were significantly higher and ejection fraction was significantly lower (46% vs. 51.4%; p < 0.001) in Group 2. Patients in Group 2 more often required complex stenting techniques (33.3% vs. 16.2%; p = 0.001). The procedure success rates were very high and did not differ between groups (100% vs. 99.2%; p = 0.882). We observed no difference in periprocedural complication rates (12.7% vs. 7.8%; p = 0.198), but the long-term all-cause mortality rate was higher in Group 2 (26% vs. 21%; p = 0.031). LM PCI in patients disqualified from CABG is an effective and safe procedure with a low in-hospital complication rate. Long-term results are satisfactory.

摘要

本研究旨在评估冠状动脉旁路移植术(CABG)禁忌患者行左主干经皮冠状动脉介入治疗(LM PCI)的短期和长期疗效。我们纳入了459例患者(平均年龄:68.4±9.4岁,女性占24.4%),随访时间至少1年;其中396例患者接受PCI作为CABG的替代方案(第1组);63例患者被心脏团队判定为CABG禁忌(第2组)。第2组的SYNTAX评分(29.1±9.5 vs. 23.2±9.7;p<0.001)和欧洲心脏手术风险评估系统II值(2.72±2.01 vs. 2.15±2.16;p = 0.007)显著更高,射血分数显著更低(46% vs. 51.4%;p<0.001)。第2组患者更常需要复杂的支架置入技术(33.3% vs. 16.2%;p = 0.001)。手术成功率非常高,两组之间无差异(100% vs. 99.2%;p = 0.882)。我们观察到围手术期并发症发生率无差异(12.7% vs. 7.8%;p = 0.198),但第2组的长期全因死亡率更高(26% vs. 21%;p = 0.031)。CABG禁忌患者行LM PCI是一种有效且安全的手术,院内并发症发生率低。长期结果令人满意。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3c/8953089/be1a2ebf01f4/jpm-12-00348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3c/8953089/be1a2ebf01f4/jpm-12-00348-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da3c/8953089/be1a2ebf01f4/jpm-12-00348-g002.jpg

相似文献

1
Short- and Long-Term Outcomes of Left Main Coronary Artery Stenting in Patients Disqualified from Coronary Artery Bypass Graft Surgery.冠状动脉旁路移植手术禁忌患者行左主干冠状动脉支架置入术的短期和长期预后
J Pers Med. 2022 Feb 25;12(3):348. doi: 10.3390/jpm12030348.
2
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.
3
Three-year outcomes after percutaneous coronary intervention and coronary artery bypass grafting in patients with heart failure: from the CREDO-Kyoto percutaneous coronary intervention/coronary artery bypass graft registry cohort-2†.心力衰竭患者经皮冠状动脉介入治疗和冠状动脉旁路移植术后的三年结局:来自CREDO-京都经皮冠状动脉介入治疗/冠状动脉旁路移植登记队列-2†
Eur J Cardiothorac Surg. 2015 Feb;47(2):316-21; discussion 321. doi: 10.1093/ejcts/ezu131. Epub 2014 Mar 23.
4
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.冠状动脉旁路移植术与经皮冠状动脉介入治疗支架置入治疗冠状动脉疾病的死亡率:一项个体患者数据的合并分析。
Lancet. 2018 Mar 10;391(10124):939-948. doi: 10.1016/S0140-6736(18)30423-9. Epub 2018 Feb 23.
5
Long-term outcomes and comparison after conventional coronary artery bypass grafting for left main disease between patients classified as percutaneous coronary intervention recommendation classes II and III.对于被归类为经皮冠状动脉介入治疗推荐等级为II级和III级的患者,在接受传统冠状动脉搭桥术治疗左主干病变后的长期预后及比较。
Eur J Cardiothorac Surg. 2014 Mar;45(3):431-7. doi: 10.1093/ejcts/ezt429. Epub 2013 Aug 26.
6
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.冠状动脉旁路移植术与经皮冠状动脉介入治疗在三支病变合并左主干病变患者中的比较:随机、临床 SYNTAX 试验的 5 年随访结果。
Lancet. 2013 Feb 23;381(9867):629-38. doi: 10.1016/S0140-6736(13)60141-5.
7
Long-term results of stenting versus coronary artery bypass surgery for left main coronary artery disease-A single-center experience.左主干冠状动脉疾病支架置入术与冠状动脉搭桥手术的长期结果——单中心经验
J Chin Med Assoc. 2016 Jul;79(7):356-62. doi: 10.1016/j.jcma.2016.01.005. Epub 2016 Feb 28.
8
Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.多支血管病变和/或无保护左主干病变患者行冠状动脉支架置入术或旁路移植术的个体长期死亡率预测:SYNTAX II 评分模型在 BEST 和 PRECOMBAT 随机对照试验 1480 例患者中的外部验证。
JACC Cardiovasc Interv. 2016 Aug 8;9(15):1564-72. doi: 10.1016/j.jcin.2016.04.023.
9
Clinical outcomes of patients with multivessel coronary artery disease treated with robot-assisted coronary artery bypass graft surgery versus one-stage percutaneous coronary intervention using drug-eluting stents.接受机器人辅助冠状动脉旁路移植手术与使用药物洗脱支架的一期经皮冠状动脉介入治疗的多支冠状动脉疾病患者的临床结局。
Medicine (Baltimore). 2019 Sep;98(38):e17202. doi: 10.1097/MD.0000000000017202.
10
Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II.EXCEL 试验中依维莫司洗脱支架与冠状动脉旁路移植术治疗左主干血运重建效果的长期预测和死亡率比较:SYNTAX 评分 II 的前瞻性验证。
Eur Heart J. 2015 May 21;36(20):1231-41. doi: 10.1093/eurheartj/ehu518. Epub 2015 Jan 12.

引用本文的文献

1
Peri-Procedural Troponin Elevation after Percutaneous Coronary Intervention for Left Main Coronary Artery Disease.左主干冠状动脉疾病经皮冠状动脉介入治疗后的围手术期肌钙蛋白升高
J Clin Med. 2022 Dec 28;12(1):244. doi: 10.3390/jcm12010244.

本文引用的文献

1
Long-Term Clinical Impact of Intravascular Ultrasound Guidance in Stenting for Left Main Coronary Artery Disease.血管内超声指导左主干冠状动脉疾病支架置入的长期临床影响。
Circ Cardiovasc Interv. 2021 Oct;14(10):e011011. doi: 10.1161/CIRCINTERVENTIONS.121.011011. Epub 2021 Oct 19.
2
The European bifurcation club Left Main Coronary Stent study: a randomized comparison of stepwise provisional vs. systematic dual stenting strategies (EBC MAIN).欧洲分叉俱乐部左主干冠状动脉支架研究:分步临时与系统双支架策略的随机比较(EBC MAIN)。
Eur Heart J. 2021 Oct 1;42(37):3829-3839. doi: 10.1093/eurheartj/ehab283.
3
Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial.
多中心、随机对照研究:复杂冠状动脉分叉病变患者中双支架技术与临时支架置入技术的比较——DEFINITION II试验
Eur Heart J. 2020 Jul 14;41(27):2523-2536. doi: 10.1093/eurheartj/ehaa543.
4
Prognostic Effects of Treatment Strategies for Left Main Versus Non-Left Main Bifurcation Percutaneous Coronary Intervention With Current-Generation Drug-Eluting Stent.当前代药物洗脱支架经皮冠状动脉介入治疗左主干与非左主干分叉病变的治疗策略的预后影响。
Circ Cardiovasc Interv. 2020 Feb;13(2):e008543. doi: 10.1161/CIRCINTERVENTIONS.119.008543. Epub 2020 Feb 7.
5
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.左主干病变行经皮冠状动脉介入治疗和冠状动脉旁路移植术后大围术期心肌梗死对死亡率的影响:来自 EXCEL 试验的分析。
Eur Heart J. 2019 Jun 21;40(24):1930-1941. doi: 10.1093/eurheartj/ehz113.
6
Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention.接受经皮冠状动脉介入治疗的左主干远端患者的结果。
Circ Cardiovasc Interv. 2018 Oct;11(10):e007007. doi: 10.1161/CIRCINTERVENTIONS.118.007007.
7
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
8
Fourth Universal Definition of Myocardial Infarction (2018).心肌梗死的第四次全球定义(2018年)。
J Am Coll Cardiol. 2018 Oct 30;72(18):2231-2264. doi: 10.1016/j.jacc.2018.08.1038. Epub 2018 Aug 25.
9
Long-term results after PCI of unprotected distal left main coronary artery stenosis: the Bifurcations Bad Krozingen (BBK)-Left Main Registry.无保护左主干远端狭窄经皮冠状动脉介入治疗的长期结果:分叉巴德克罗伊茨宁(BBK)-左主干注册研究。
Clin Res Cardiol. 2019 Feb;108(2):175-184. doi: 10.1007/s00392-018-1337-9. Epub 2018 Jul 26.
10
Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club.经皮冠状动脉介入治疗左主干冠状动脉疾病:欧洲分叉俱乐部第 13 次共识文件。
EuroIntervention. 2018 May 20;14(1):112-120. doi: 10.4244/EIJ-D-18-00357.